Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

5005 ORAL Exploratory Subgroup Analysis of the TAMRAD Phase 2 GINECO Trial Comparing Tamoxifen (TAM) Plus Everolimus (RAD) With TAM Alone in Patients With Hormone-receptor-positive, HER2-negative Metastatic Breast Cancer (mBC) With Prior Exposure to Aromatase Inhibitors (Als): Implication for Research Strategies

C Bourqier, Isabelle Raycoquard,J Provencal,Claire Cropet,A V Bourcier,Valerie Delecroix,A Reynaudbougnoux,J Cretin,T Bachelot

European Journal of Cancer（2011）

Cited 5|Views19
No score
Key words
gineco trial comparing tamoxifen,aromatase inhibitors,breast cancer,tamrad,hormone-receptor-positive
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined